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AbStrACt
background: Percutaneous closure of patent ductus arteriosus 
is a safe, effective and easily reproducible method. Adult 
patent ductus arteriosus may present degenerative changes 
that increase surgical risk and favor percutaneous closure. 
We report a single center experience with percutaneous 
closure of patent ductus arteriosus in adults and highlight 
specific technical aspects of this procedure. Methods: The 
records of patients ≥ 20 years of age submitted to patent 
ductus arteriosus closure between March 2001 and December 
2012 were evaluated. Cases were selected by transthoracic 
echocardiography. results: We analyzed 33 patients, most of 
them females (72.7%), with mean age of 30.9 ± 12.8 years 
and weight of 63.9 ± 12.4 kg. Only 3 patients had symptoms 
and 2 had associated congenital defects, treated in the same 
procedure. Implants were possible in all cases. One Flipper 
Coil, 19 AmplatzerTM Duct Occluders type I, 3 AmplatzerTM 
Duct Occluders type II, 8 CeraTM PDA Occluders and 2 Mus-
cular VSD devices were used. Sizing balloons were used in 
5 cases. Mean follow-up was 46.1 ± 42.9 months and was 
obtained in 84.9% of patients. Two cases presented residual 
shunts immediately after the procedure. There were no major 
complications or deaths. Conclusions: Percutaneous closure of 
adult patent ductus arteriosus may be performed safely and 
effectively with the devices used in this study.
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rESUMO
Aspectos Particulares da Oclusão Percutânea  
do Canal Arterial do Adulto
Introdução: A oclusão percutânea do canal arterial é um 
método seguro, eficaz e facilmente reproduzível. O canal 
arterial do adulto pode apresentar alterações degenerativas, 
que aumentam o risco da cirurgia e favorecem o procedimento 
percutâneo. Descrevemos a experiência de um centro único 
com a oclusão percutânea do canal arterial em adultos e 
destacamos aspectos técnicos particulares desse procedimento. 
Métodos: Revisamos os registros de todos os pacientes > 20 
anos de idade submetidos a oclusão do canal arterial entre 
março de 2001 e dezembro de 2012. Os casos foram selecio-
nados por ecocardiografia transtorácica. resultados: Analisa-
mos 33 pacientes, a maioria do sexo feminino (72,7%), com 
médias de idade de 30,9 ± 12,8 anos e de peso de 63,9 ± 
12,4 kg. Somente 3 pacientes tinham sintomas e 2 pacientes 
apresentaram defeitos associados, tratados no mesmo pro-
cedimento. Os implantes foram possíveis em todos os casos. 
Foram utilizadas 1 mola Flipper, 19 próteses AmplatzerTM 
Duct Occluder tipo I, 3 próteses AmplatzerTM Duct Occluder 
tipo II, 8 próteses CeraTM PDA Occluder e 2 próteses para 
comunicação interventricular muscular. O uso de balões me-
didores foi necessário em 5 casos. O seguimento médio foi 
de 46,1 ± 42,9 meses e foi obtido em 84,9% dos pacientes. 
Dois casos apresentaram shunt residual imediatamente após 
o procedimento. Não ocorreram complicações maiores ou 
óbitos. Conclusões: A oclusão percutânea dos canais dos 
adultos com os dispositivos empregados pode ser realizada 
com segurança e eficácia.
DESCrItOrES: Permeabilidade do canal arterial. Próteses e 
implantes. Cardiopatias congênitas. Adulto.
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Percutaneous closure of ductus arteriosus is, cur-rently, the therapeutic choice in all centers capable of performing procedures in interventional cardi-
ology.1-7 Although it is a relatively simple procedure 
when performed in children weighing > 5 kg, some 
characteristic features are found in adult ductus arte-
riosus. Anatomical and morphological changes may be 
present, such as aneurysms, calcifications, diverticula, 
and friability of the ductal tissue, which increase the 
surgical risk and favour the option of transcatheter 
closure.8-14 Late complications are also reported in the 
evolution of untreated ductus arteriosus in adults, espe-
cially endarteritis, arrhythmias, ventricular dysfunction, 
and progressive pulmonary arterial hypertension.15-17
The transcatheter closure of adult patent ductus 
arteriosus (PDA) exhibits a few difficulties and requires 
specific care.3,8,18 This study reports the group’s expe-
rience with percutaneous closure of PDA in adults, 
discussing available options and techniques in detail.
Method
Study design
This was a retrospective single-arm study, carried 
out in a single center (Interventional Cardiology – 
INTERCAT, Rio de Janeiro, RJ, Brazil), which included 
all adult patients undergoing PDA closure with different 
devices, between March 2001 and December 2012.
Patient selection
Records of all patients ≥ 20 years of age, with 
ductus arteriosus and indication for percutaneous clo-
sure without associated defects that required surgical 
correction were reviewed. The cases were selected by 
means of transthoracic echocardiography with colour 
flow mapping. The dimensions and morphology of the 
defects were not used as exclusion criteria.
Implantation techniques
All patients received general anesthesia and under-
went tracheal intubation. Sodium heparin at a dose of 
5,000 U plus 2 g of intravenous cefazolin, as antibiotic 
prophylaxis, were administered. The femoral artery and 
vein were punctured, and left and right catheterizations 
were performed with pressure recordings. Oximetry 
was performed only in cases where it was necessary 
to study the pulmonary vascular reactivity.
Descending thoracic aorta angiograms were ob-
tained in the right anterior oblique and left lateral 
view using a 5F pigtail catheter. Angiograms were 
analyzed regarding shape, according to the classifi-
cation of Krichenko et al.,19 and the dimensions of 
the ductus arteriosus, with special emphasis on its 
smallest diameter. Some ductae showed significant 
constriction in the pulmonary end, and it was decided 
to attribute the value of 1 mm to its smallest diam-
eter. In this case, when it was impossible to cross 
them by the antegrade route, they were accessed via 
arterial route, and the rigid exchange guide wire was 
captured with a 15 mm or 20 mm catheter loop in 
the main pulmonary artery and externalized through 
the venous sheath. Subsequently, the long sheath 
compatible with the selected device was advanced 
through the vein to the descending aorta, and the 
device was implanted in the usual way.20
In cases where the angiograms were unable to outline 
the ductus for morphological analysis and measurement, 
a partially insufflate sizing balloon, with contrast diluted 
in saline solution, was introduced intravenously into 
the descending aorta over the guidewire, to occlude 
the interatrial septal defect, allowing the contrast to be 
ejected into the pulmonary artery through the ductus 
arteriosus. The frames were reviewed in slow motion 
to verify the exact time of passage through the ductus, 
making it possible to outline its shape, safely measuring 
its smaller diameter.20 The different prostheses used were 
selected with diameters at least 2 mm larger than the 
smallest diameter of the ductus arteriosus, according to 
the protocols of the respective implant manufacturers, 
as previously reported.20-23
Follow-up was performed by transthoracic echo-
cardiography, seeking residual flows24 and obstructions 
in the descending aorta and left pulmonary branch 
on the day following implantation, one month, three 
months, and six months after the procedure, and an-
nually thereafter. Prophylaxis for infective endocarditis 
was indicated for six months following the implant.
Statistical Analysis
Continuous variables were expressed as means and 
standard deviations, and categorical variables as num-
bers and percentages. This study aimed to demonstrate 
the group’s experience with the closure of the ductus 
arteriosus in adult patients, and thus, comparisons 
between devices were not performed.
ReSultS
The records of 33 patients submitted to percu-
taneous closure of patent ductus arteriosus between 
March 2001 and December 2012 were retrospectively 
analyzed, of whom 72.7% were females. Ages ranged 
from 20 to 66 years (30.9 ± 12.8 years) and weight 
from 38 kg to 92 kg (63.9 ± 12.4 kg). Three patients 
complained of dyspnoea on exertion (patients 5-RSS, 
15-LEF, and 25-JOC), and two patients (10-SCFA and 
30-LCMM) had severe pulmonary arterial hypertension 
and were categorized in New York Heart Association 
(NYHA) functional class III. One patient (33-GOR) also 
presented an atrial septal defect that was closed with an 
18-mm CeraTM prosthesis (Lifetech – Shenzhen, China) 
in the same procedure. Another patient (13-NNFO) had 
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mesocardia with left pulmonary sequestration, and one 
patient was deaf-mute (15-LEF).
The smallest ductus diameters varied from 1 mm 
to 10 mm (4.9 ± 2.8 mm). Regarding the morphology, 
the assessed ductae were type A in 76%, type C in 
9%, type D in 6%, and type E in 9%. None showed 
significant tissue degeneration or calcification (Table 
1). The implantation was feasible in all cases. One 
Flipper coil 5PDA5 (Cook Medical Inc., Bloomington, 
United States), 19 AmplatzerTM Duct Occluders type I 
(ADO I; AGA – Golden Valley, United States) (three 6-4 
table  
Study population
Number Identification Gender
Age 
(years)
Morphologic 
type
Diametera 
(mm)
PSAP 
(mmHg) Prosthesis
Immediate 
result
1 LER F 20 E 1 22 Mola Flipper 
5PDA5
Closed
2 RRMF F 38 A 4.5 28 ADO I 8-6 Closed
3 IRC F 22 A 3.5 32 ADO I 10-8 Closed
4 P8 F 21 A 2.5 21 ADO I 6-4 Closed
5 RSS F 24 A 2 24 ADO I 8-6 Closed
6 FBS M 42 A 8 22 ADO I 12-10 Closed
7 MBM F 22 C 4 22 ADO I 10-8 Closed
8 MGSS F 42 A 4 32 ADO I 12-10 Closed
9 PEPS F 30 A 5 33 ADO I 10-8 Closed
10 SCFA F 50 A 8 85 AMVSD 12 Closed
11 MNM F 21 A 2 36 ADO I 6-4 Closed
12 AOG F 20 A 10 31 ADO I 12-10 Closed
13 NNFO F 21 A 1 28 ADO I 6-4 Closed
14 VPO M 22 E 3.5 27 ADO I 10-8 Closed
15 LEF M 30 A 8 30 ADO I 12-10 Minimal shunt
16 FAAE F 23 A 6 17 ADO I 12-10 Minimal shunt
17 NMO F 66 D 6 18 ADO I 12-10 Closed
18 JU F 62 A 6 34 ADO I 12-10 Closed
19 JJMA M 24 A 6 43 ADO I 12-10 Closed
20 VS F 32 A 2.5 23 ADO I 8-6 Closed
21 IFP M 29 A 6 32 ADO I 12-10 Closed
22 AVA F 21 A 3 24 ADO II 6-4 Closed
23 APNS F 34 A 4 22 ADO II 5-4 Closed
24 ECAS F 44 A 3.5 35 ADO II 5-4 Closed
25 JOC M 27 A 6 42 CPO 12-10 Closed
26 G88 M 20 E 1 39 CPO 6-4 Closed
27 LHL F 20 A 1 39 CPO 6-4 Closed
28 SLRM M 33 A 8 20 CPO 12-10 Closed
29 LSG F 30 C 7 42 CPO 12-10 Closed
30 LCMM F 35 C 10 95 CMVSD 16 Closed
31 MFP F 43 A 6 31 CPO 12-10 Closed
32 LPCS M 23 A 1 23 CPO 8-6 Closed
33 GOR F 29 D 3 24 CPO 8-6 Closed
a Smallest diameter observed.
PASP, pulmonary artery systolic pressure; F, Female; ADO, AmplatzerTM Duct Occluder; M, Male; AMVSD; CPO, CeraTM PDA Occluder; 
CMVSD, CeraTM Muscular VSD Occluder.
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restrictive VSD remaining open. After a complicated 
evolution, immediately after the second procedure, 
the patient is in NYHA functional class II, undergoing 
treatment protocol for pulmonary arterial hypertension 
with sildenafil and bosentan. Another patient (10-SCFA) 
with pulmonary arterial hypertension showed significant 
atrial fibrillation with low ventricular response. The 
PDA was successfully closed with a 12-mm AMVSD 
prosthesis, and she presented severe hemodynamic 
instability immediately after the procedure, requiring 
temporary pacemaker implantation, followed by a 
permanent pacemaker. The patient was discharged 
in good condition with a fully closed PDA, and is in 
good clinical condition seven years later.
Immediately after the procedure, only two patients 
had minimal residual shunt, with no gushing inside 
the devices (ADO I 12-10 prostheses in both cases), 
which were completely closed in the transthoracic 
echocardiography performed in the first postoperative 
month. Follow-up was achieved in 84.9% of patients, 
and ranged from three to 132 months (46.1 ± 42.9 
months). No case had a gradient in the descending 
aorta or in the left branch of the pulmonary artery. 
The only complication was a right femoral pseudoa-
neurysm in a 62-year-old patient (18-JU), resolved by 
local compression through the ultrasound transducer; 
the hematoma was reasorbed by applying local heat 
and anti-inflammatory drug use. There were no deaths 
in the present series.
dIScuSSIon
The percutaneous closure of adult PDA has some 
aspects that differentiate it from procedures in children. 
The correct viewing of the ductus through conventional 
angiography is sometimes extremely difficult. The high 
flow through the defect, associated to the large diameter 
of the adult aorta, may prevent its measurement by 
conventional angiography. In such cases, the solution 
is to use sizing balloons, which, similar to the evalua-
tion of the stretched diameter of septal defects, slightly 
distend the ductus, and during the passage from the 
descending aorta through the ductus to the pulmonary 
prostheses, three 8-6 prostheses, five 10-8 prostheses, 
and eight 12-10 prostheses), three ADO II prostheses 
(two 5-4 prostheses and one 6-4 prosthesis), eight 
CeraTM PDA Occluders (CPO; two 6-4 prostheses, two 
8-6 prostheses, and four 12-10 prostheses), one 12-
mm AmplatzerTM Muscular VSD prosthesis Occluder 
(AMVSD) and one 16-mm CeraTM Muscular VSD pros-
thesis Occluder (CMVSD). Angiography was not capable 
of clearly delineating the shape and size of the ductus 
arteriosus in five cases: four type A, measuring 3.3 
mm, 6 mm, 6 mm, and 8 mm, and one type C, which 
measured 10 mm. In these cases, 24-mm AGA sizing 
balloons were used in ductus type A and a 30-40 mm 
PTS sizing balloon (Numed, Hopkinton, USA) was used 
in type C ductus, which is larger (Figure 1).
The prevalence of large calibre ductus arteriosus 
was a frequent finding in adults, but the smaller 
diameter of the ductus arteriosus showed no correla-
tion with systolic pressure in the pulmonary artery. 
Pulmonary systolic pressure ranged from 17 mmHg to 
95 mmHg (33.8 ± 17.6 mmHg) and was > 30 mmHg 
in 51.5% of patients. One patient (30-LCMM) with 
severe pulmonary arterial hypertension and pulmonary 
vascular resistance of 4.1 Wood U had multiple VSD, 
also known as “Swiss cheese” ventricular septum, 
associated with a 10-mm type C ductus arteriosus, 
which was closed using a 16-mm CMVSD prosthesis 
(Figure 2). Two other muscular VSDs were closed in 
the same procedure. In a second session, three more 
sizeable muscular VSDs were closed, with a single 
Figure 1 – Ductus arteriosus type A, of large calibre (8 mm), outlined 
with the help of a 24-mm AGA sizing balloon. The mark in the bal-
loon corresponds to the smallest diameter in the ductus arteriosus, 
in the pulmonary end. Ao, aorta; PA, pulmonary artery; PDA, patent 
ductus arteriosus.
Figure 2 – In A, descending aortography in lateral view showing 
tubular ductus arteriosus type C, measuring 10 mm. In b, occlusion 
with 16-mm CeraTM Muscular VSD Occluder prosthesis still connected 
to the delivery catheter. The aortography shows no residual shunt.
Ao
PDA
PA
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trunk, accurately outline the defect diameter, allowing 
the morphological analysis and accurate measurement 
so that the appropriate device can be chosen. In the 
present study, this technique was necessary in five 
cases, and was successful in all.
Another problem to be addressed is that the natu-
ral elasticity of the ductus arteriosus is underestimated 
by angiography, which draws its outline only at the 
moment of contrast injection, of but is not capable of 
assessing its distended diameter. In some cases, the 
ductus arteriosus appeared too small or to have a severe 
narrowing at its pulmonary end, but it was crossed by 
a diagnostic catheter, without any difficulty, allowing 
for the use of larger-calibre prostheses than initially 
estimated (Figure 3). The stringent oversizing of devices 
increases procedural safety, preventing embolization. 
It is of utmost importance that the ADO I and CPO 
devices are positioned so that they are compressed in 
their middle portion by the smallest diameter of the 
ductus arteriosus, leaving the pulmonary end slightly 
dilated, preventing slippage of the prosthesis into the 
descending aorta.
Although some patients had large-calibre ductus 
arteriosus, pulmonary arterial pressure was not com-
paratively high in most cases. This might have been 
due to the length of the ductus, which attenuates the 
transmission of systemic pressure to the pulmonary 
artery. In cases with pulmonary hypertension, increase 
in the systolic pulmonary pressure was considered mild 
(< 1/3 of the systemic pressure); it was > 40 mm Hg in 
five cases, of which only two had pressure > 75% of 
systemic levels. In both cases in which the pulmonary 
arterial pressure was very high, prostheses were used 
to occlude the muscular VSD (12 mm AMVSD and 
16-mm CMVSD) for safety reasons. Sizing balloons 
were also used in both cases (24 mm AGA and 30-40 
mm PTS).25-27
concluSIonS
The percutaneous closure of the ductus arteriosus 
in adults can be performed quite safely and effectively 
using traditional techniques and available devices. 
When the analysis of the ductus arteriosus shape and 
size cannot be performed satisfactorily by conventional 
angiography, the use of a sizing balloon is a strategy 
that can be used to overcome this limitation.
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